Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 28;22(3):344-350.
doi: 10.26599/1671-5411.2025.03.004.

Predicting survival in atrial fibrillation: results from SAGE-AF

David C Parish  1 , Catarina I Kiefe  2 , Jordy Mehawej  3 , Edith Mensah Otabil  3 , Carly N Beniek  3 , Francis C Dane  4
Affiliations

Predicting survival in atrial fibrillation: results from SAGE-AF

David C Parish et al. J Geriatr Cardiol. .

Abstract

Background: Using Systematic Assessment of Geriatric Elements in Atrial Fibrillation (SAGE-AF) data, determine how well the rich mix of demographic, clinical history, geriatric assessments, and clinically adjudicated events can predict two-year survival.

Methods: Subjects were recruited from participating outpatient practices if they had non-valvular AF, were 65 or over with CHA2DS2-VASc scores of at least 2, and were candidates for anticoagulation. Demographics, clinical history, and geriatric qualities of life were assessed by interview and medical records review using standardized protocols and repeated at one and two years. Events identified were abstracted and submitted for adjudication using standard definitions of events and categories. Non-mortality event categories included hospitalizations (cardiovascular, bleeding, other), bleeding (major, clinically relevant non-major, minor), and seven major adverse cardiovascular events.

Results: The 1245 subjects experienced 1960 events, primarily hospitalizations (935) and/or bleeding (817); 114 subjects (9.2%) died during two years of follow-up. Events initially abstracted to more than one category (172) were combined, resulting in 1788 unique incidents. Most subjects had zero or one event (69%) and fewer than 7% had more than 3 types. Most variables were significant in bivariate analysis. Using multiple logistic regression with two-year survival as the outcome variable, the best-fit model included event number and type, number of unique incidents, and number of bleeding events (R2 = 0.511, C = 93.1) with sensitivity = 97.9% and specificity = 44.7%.

Conclusions: Two-year survival was high. This model, if validated, could have major implications for treatment of patients with AF. Patients in the large group with no or one event are at very low risk of death (under 2%). The small group with high risk for further complications, including death, deserve reassessment to determine if this trajectory can be altered.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Survival of subjects as a function of number of different types of events: SAGE-AF, 2016−2020. SAGE-AF: systematic assessment of geriatric elements in atrial fibrillation.
Figure 2
Figure 2
Effect of variables in the model on survival in SAGE-AF (2016−2020). SAGE-AF: systematic assessment of geriatric elements in atrial fibrillation.
See this image and copyright information in PMC

References

    1. Virani SS, Alonso A, Aparicio HJ, et al. Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association. Circulation 2021; 143: e254-e743.

    1. Chugh SS, Havmoeller R, Narayanan K, et al Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837–847. - PMC - PubMed
    1. Cheung CC, Nattel S, Macle L, Andrade JG Management of atrial fibrillation in 2021: an updated comparison of the current CCS/CHRS, ESC, and AHA/ACC/HRS Guidelines. Can J Cardiol. 2021;37:1607–1618. - PubMed
    1. Benjamin EJ, Wolf PA, D’Agostino RB, et al Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–952. - PubMed

    1. Sankaranarayanan R, Kirkwood G, Visweswariah R, Fox D. How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era? Curr Cardiol Rev. 2015;11(3): 190-198.

LinkOut - more resources